1. Defossez G, Le Guyader‐Peyrou S, Uhry Z, Grosclaude P, Colonna M, Dantony E, Molinié F, Woronoff A-S, Bouvier A-M, Bossard N, Remontet L, Monnereau I (2019) Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Voulume 1: Tumeurs Solides/Vessie, Institut National du Cancer. https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Synthese-Estimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-France-metropolitaine-entre-1990-et-20182 Accessed October 22, 2021
2. Ismail S, Karsenty G, Chartier-Kastler E, Cussenot O, Compérat E, Rouprêt M, Phé V (2018) Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: a systematic review. Neurourol Urodyn 37:1386–1395. https://doi.org/10.1002/nau.23457
3. Böthig R, Kowald B, Fiebag K, Balzer O, Tiburtius C, Thietje R, Kadhum T, German-speaking Medical SCI Society (DMGP) Bladder Cancer Extended Working Group, Golka K (2021) Bladder management, severity of injury and period of latency: a descriptive study on 135 patients with spinal cord injury and bladder cancer. Spinal Cord 59:971–977. https://doi.org/10.1038/s41393-021-00651-3
4. Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS (2004) Spina bifida. Lancet 364:1885–1895. https://doi.org/10.1016/S0140-6736(04)17445-X
5. West DA, Cummings JM, Longo WE, Virgo KS, Johnson FE, Parra RO (1999) Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology 53:292–297. https://doi.org/10.1016/s0090-4295(98)00517-2